Hubrecht Organoid Technology

AI-plus-genomics patient-derived organoid platform for HNSCC preclinical drug response testing

Researchers grow mini versions of a patient's head and neck tumor in the lab, use AI to tell whether the mini-tumors are cancer or normal tissue, and combine that with DNA testing to see which treatments are most likely to work.